share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
美股sec公告 ·  04/17 16:21
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 23,124 Class A shares on 04/17/2024, as per the latest filing. The shares to be sold were acquired through various means including Pre IPO Option Exercise, Restricted Stock Vesting, and ESPP Purchase, with acquisition dates ranging from 04/20/2021 to 02/15/2023. The transactions were made either as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 127,500 shares were sold for gross proceeds of approximately $1.49 million.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 23,124 Class A shares on 04/17/2024, as per the latest filing. The shares to be sold were acquired through various means including Pre IPO Option Exercise, Restricted Stock Vesting, and ESPP Purchase, with acquisition dates ranging from 04/20/2021 to 02/15/2023. The transactions were made either as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 127,500 shares were sold for gross proceeds of approximately $1.49 million.
根据最新文件，Recursion Pharmicals, Inc.高管塞科拉·迈克尔定于2024年4月17日出售23,124股A类股票。待售股票是通过各种方式收购的，包括首次公开募股前期权行使、限制性股票归属和ESPP购买，收购日期从2021年4月20日到2023年2月15日不等。这些交易要么作为补偿，要么通过现金支付。此次计划出售是在过去三个月进行的一系列交易之后进行的，共出售了127,500股股票，总收益约为149万美元。
根据最新文件，Recursion Pharmicals, Inc.高管塞科拉·迈克尔定于2024年4月17日出售23,124股A类股票。待售股票是通过各种方式收购的，包括首次公开募股前期权行使、限制性股票归属和ESPP购买，收购日期从2021年4月20日到2023年2月15日不等。这些交易要么作为补偿，要么通过现金支付。此次计划出售是在过去三个月进行的一系列交易之后进行的，共出售了127,500股股票，总收益约为149万美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息